Forum für Wissenschaft, Industrie und Wirtschaft

Hauptsponsoren:     3M 
Datenbankrecherche:

 

Preliminary study finds stem cells in blood restore damaged heart muscle

21.10.2003


Proves adult stem cells from blood can repair heart



Based on promising animal data, researchers at The University of Texas M. D. Anderson Cancer Center say that cells taken from a patient’s own blood may one day be able to repair heart tissue that has been damaged.

While other researchers have shown that stem cells derived from bone marrow and umbilical cord blood can regenerate cardiac tissue, this study demonstrates that adult stem cells circulating in blood can also repair a heart.


In the study, published online in the current issue of the journal Circulation, the scientists found that human blood stem cells -- "master" cells that produce other types of body cells as needed -- regenerated heart muscle cells as well as artery tissue in mice whose hearts were injured.

"This takes us a big step ahead," says the lead author, Edward T. H. Yeh, M.D., professor and chair of M. D. Anderson’s Department of Cardiology. "Taking stem cells from blood is a lot easier, and a lot less painful, than taking it from bone marrow.

"For patients, it would be as simple as donating blood," he says. "We would then isolate these potent cells and give them back to the patient where the damage has occurred."

While the researchers are cardiologists and cancer specialists, and are interested in treating heart failure that occurs in up to 10 percent of patients who use chemotherapy, they say such cell-based regeneration therapy could benefit patients who have had a heart attack or other injuries that have led to heart failure. "Such a therapy cannot bring back dead heart muscle, but it can help restore weakened hearts, no matter what the cause of the damage was," says Yeh.

The research also contributes more evidence to the idea that stem cells circulating in the blood can transform themselves into different organ systems as needed to repair injury -- a notion dubbed "stem cell plasticity" that is both revolutionary and controversial. The theory, pioneered by M. D. Anderson researchers Martin Körbling, M.D., and Zeev Estrov, M.D., upsets longstanding beliefs that different kinds of tissue have their own supply of stem cells to repair damage. If correct, however, stem cell plasticity could be used to repair, or even replace tissues and organs injured by cancer, say Körbling and Estrov, who are co-authors on this study.

To conduct the study, the researchers collected a supply of human stem cells from what is generally regarded as debris from the process of banking human red blood. (After blood is collected from volunteers, it is separated into white and red blood cells, and the white blood cells are usually thrown away.) The scientists collected white blood cells and then searched for those cells that express a protein (CD34+) that is known to be associated with stem cells. They then isolated cells with the CD34+ marker from the white cells.

To test whether peripheral blood stem cells could regenerate tissue, the research team used two groups of mice that were engineered not to have an immune system, so that they would not reject human cells. One group of mice was given an artificially induced heart attack, and then immediately treated with an injection of the human stem cells. The other mice, with healthy hearts, also received the stem cell therapy.

The researchers found that in mice with an injured heart, new cardiac muscle cells (myocytes) had developed at the edge of damaged tissue, and several layers of new blood vessel tissue (endothelial and smooth muscle cells) had also grown. Little evidence of such repair was found in the mice with healthy hearts, says Yeh.

"We’ve shown that CD34+-associated cells can actually transform into three different cells used by the heart, and that tissue damage is critical to this process," he says.

Several sources for regenerative stem cells have been suggested, such as bone marrow, cord blood and embryonic cells, but this study "demonstrates that adult blood stem cells may be an alternative to these other sources of cells for myocardial regeneration," says Yeh. "And blood is a readily available source of stem cells that does not require significant manipulation."

Yeh notes that no stem cell protocol has been approved in the United States to date, and that most human trials using stem cells (those derived from bone marrow) have taken place in Europe and South America. Still, Yeh says he hopes his research can advance in the near future.


The study was funded by M. D. Anderson.

Co-authors include Estrov, a professor of the Division of Bioimmunotherapy; Körbling, a professor in the Bone Marrow Transplantation Program; and Sui Zhang, M.D., Ph.D., all of M. D. Anderson. Also collaborating on the study were Henry D. Wu, M.D, and James T. Willerson, M.D., of The University of Texas Health Science Center at Houston. Yeh carries a joint appointment at The Health Science Center and the Texas Heart Institute.

Written by Renee Twombly

Laura Sussman | EurekAlert!

Weitere Nachrichten aus der Kategorie Medizin Gesundheit:

nachricht Sind Epilepsie-Patienten wetterfühlig?
23.05.2017 | Universitätsklinikum Jena

nachricht Dual-Layer Spektral-CT: Bessere Therapieplanung beim Bauchspeicheldrüsenkrebs
18.05.2017 | Deutsche Röntgengesellschaft e.V.

Alle Nachrichten aus der Kategorie: Medizin Gesundheit >>>

Die aktuellsten Pressemeldungen zum Suchbegriff Innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Neue Methode für die Datenübertragung mit Licht

Der steigende Bedarf an schneller, leistungsfähiger Datenübertragung erfordert die Entwicklung neuer Verfahren zur verlustarmen und störungsfreien Übermittlung von optischen Informationssignalen. Wissenschaftler der Universität Johannesburg, des Instituts für Angewandte Optik der Friedrich-Schiller-Universität Jena und des Leibniz-Instituts für Photonische Technologien Jena (Leibniz-IPHT) präsentieren im Fachblatt „Journal of Optics“ eine neue Möglichkeit, glasfaserbasierte und kabellose optische Datenübertragung effizient miteinander zu verbinden.

Dank des Internets können wir in Sekundenbruchteilen mit Menschen rund um den Globus in Kontakt treten. Damit die Kommunikation reibungslos funktioniert,...

Im Focus: Strathclyde-led research develops world's highest gain high-power laser amplifier

The world's highest gain high power laser amplifier - by many orders of magnitude - has been developed in research led at the University of Strathclyde.

The researchers demonstrated the feasibility of using plasma to amplify short laser pulses of picojoule-level energy up to 100 millijoules, which is a 'gain'...

Im Focus: Lässt sich mit Boten-RNA das Immunsystem gegen Staphylococcus aureus scharf schalten?

Staphylococcus aureus ist aufgrund häufiger Resistenzen gegenüber vielen Antibiotika ein gefürchteter Erreger (MRSA) insbesondere bei Krankenhaus-Infektionen. Forscher des Paul-Ehrlich-Instituts haben immunologische Prozesse identifiziert, die eine erfolgreiche körpereigene, gegen den Erreger gerichtete Abwehr verhindern. Die Forscher konnten zeigen, dass sich durch Übertragung von Protein oder Boten-RNA (mRNA, messenger RNA) des Erregers auf Immunzellen die Immunantwort in Richtung einer aktiven Erregerabwehr verschieben lässt. Dies könnte für die Entwicklung eines wirksamen Impfstoffs bedeutsam sein. Darüber berichtet PLOS Pathogens in seiner Online-Ausgabe vom 25.05.2017.

Staphylococcus aureus (S. aureus) ist ein Bakterium, das bei weit über der Hälfte der Erwachsenen Haut und Schleimhäute besiedelt und dabei normalerweise keine...

Im Focus: Can the immune system be boosted against Staphylococcus aureus by delivery of messenger RNA?

Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.

Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....

Im Focus: Orientierungslauf im Mikrokosmos

Physiker der Universität Würzburg können auf Knopfdruck einzelne Lichtteilchen erzeugen, die einander ähneln wie ein Ei dem anderen. Zwei neue Studien zeigen nun, welches Potenzial diese Methode hat.

Der Quantencomputer beflügelt seit Jahrzehnten die Phantasie der Wissenschaftler: Er beruht auf grundlegend anderen Phänomenen als ein herkömmlicher Rechner....

Alle Focus-News des Innovations-reports >>>

Anzeige

Anzeige

IHR
JOB & KARRIERE
SERVICE
im innovations-report
in Kooperation mit academics
Veranstaltungen

Lebensdauer alternder Brücken - prüfen und vorausschauen

29.05.2017 | Veranstaltungen

49. eucen-Konferenz zum Thema Lebenslanges Lernen an Universitäten

29.05.2017 | Veranstaltungen

Internationale Konferenz an der Schnittstelle von Literatur, Kultur und Wirtschaft

29.05.2017 | Veranstaltungen

 
VideoLinks
B2B-VideoLinks
Weitere VideoLinks >>>
Aktuelle Beiträge

Intelligente Sensoren mit System

29.05.2017 | Messenachrichten

Geckos kommunizieren überraschend flexibel

29.05.2017 | Biowissenschaften Chemie

1,5 Millionen Euro für vier neue „Innovative Training Networks” an der Universität Hamburg

29.05.2017 | Förderungen Preise